Top Abstract Purchase Related
Home
>
Node
>
Subnode

Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis

Shaplygin, L.V.; Sivakov, A.A.

Urologiia 3: 35-37; 39

2007

ISSN/ISBN: 1728-2985
PMID: 17722618
Document Number: 612891
Cernilton is a phytodrug containing pollen extract. It has antiandrogenic and anti-inflammatory effects influencing alpha1-adrenoblockers located in the zone of the detrusor and urethra. A conservative therapy with cernilton was given to 72 patients with chronic prostatitis and prostatic adenoma of stage I-II. Detailed urologic examination before the treatment and after it demonstrates that cernilton is effective, safe and well tolerated medicine for prostatic adenoma and chronic prostatitis. Cernilton is recommended for wider use in the treatment of patients with prostatic adenoma and chronic prostatitis.

Document emailed within 1 workday
Secure & encrypted payments

Aslamazov, E.G.; Akhvlediani, N.D.; Vinarov, A.Z.; Aliaev, I.G. 2007: Cernilton in the treatment of prostatic adenoma and chronic prostatitis Urologiia 1: 52; 54-56
Davidov, M.I. 2011: Treatment of prostatic adenoma with concomitant chronic bacterial prostatitis Urologiia 1: 21-28
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Hessler, D. 1981: Diagnosis of chronic prostatitis: urinary cytology following prostatic massage Helvetica Chirurgica Acta 48(3-4): 401-404
Wu, X.-j.; Yang, L.-y.; Zhang, X.-z. 2008: A clinical analysis of benign prostatic hyperplasia with chronic prostatitis Zhonghua Nan Ke Xue 14(6): 527-529
Duan, Z.-g.; Yang, W.-m. 2005: Analysis of cytokines (IL-2, IL-8, IL-10) in the expressed prostatic secretions of chronic prostatitis Zhonghua Nan Ke Xue 11(3): 201-203
Mazo, E.B.; Kozdoba, A.S. 2007: Chronic prostatitis--risk factor in development of prostatic cancer (review) Terapevticheskii Arkhiv 79(10): 66-73
Ikeuchi, T.; Ueno, M. 1993: Clinical studies on chronic prostatitis and prostatitis-like syndrome (6). Clinical evaluation for the chronic prostatitis-like syndrome patients with severe symptoms of voiding and abnormal uroflowmetric results Hinyokika Kiyo. Acta Urologica Japonica 39(4): 321-325
Yang, G.-Q.; Li, S.-W.; Zheng, H.; Zhang, W.-B.; Hu, W.-L.; Zheng, X.-M. 2009: Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis Zhonghua Nan Ke Xue 15(4): 314-317
Ding, X.-g.; Li, S.-w.; Zheng, X.-m.; Hu, L.-q. 2006: IFN-gamma and TGF-beta1, levels in the expressed prostatic secretions of patients with chronic abacterial prostatitis Zhonghua Nan Ke Xue 12(11): 982-984
Mazo, E.B.; Dmitriev, D.G. 2001: Clinical effect of the drug "Prostamol-Uno" in patients with benign prostatic hyperplasia and chronic prostatitis Urologiia 5: 38-41
Gao, W.-J.; Wang, Y.-M.; Wang, C.-H.; Yang, X.-K.; Wan, L.; Li, W.-P. 2013: Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications Zhonghua Nan Ke Xue 19(4): 315-320
Zhiborev, A.B.; Martov, A.G. 2018: The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia Urologiia 4: 81-87
Vozianov, A.F.; Mal'tsev, E.V.; Vodianik, N.V. 1995: The treatment of prostatic adenoma by transurethral microwave therapy Likars'ka Sprava 1995(1-2): 142-146
Liu, K.J.; Chatta, G.S.; Twardzik, D.R.; Vedvick, T.S.; True, L.D.; Spies, A.G.; Cheever, M.A. 1997: Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy Journal of Immunology 159(1): 472-480
Dormia, E.; Minervini, M.S.; Malagola, G.; Castellani, R.; Dormia, G.; Bertana, F.; Gonnella, G.; Luongo, P.; Mazza, L.; Longo, G. 1995: Radical versus conservative therapy in prostatic adenoma. Open adenomectomy Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 67(1): 47-51
Churakov, A.A.; Bezrukov, E.A.; Dolgov, A.B.; Butnaru, D.V.; Martirosyan, G.A.; Zakharova, N.B.; Popkov, V.M. 2019: Use of local baroimpulse therapy in the treatment of patients with chronic abacterial prostatitis / chronic pelvic pain syndrome and erectile dysfunction Urologiia 3: 108-113
Mustafaev, E.M.; Martov, A.G.; Naumov, A.G.; Siniukhin, V.N.; Shakir, F.; Merinov, D.S.; Amelin, A.V.; Al'bitskaia, A.Iu. 2007: The role of ozone therapy in prevention of pyoinflammatory complications after transurethral resection of prostatic adenoma Urologiia 2007(1): 18-23 27
Karpukhin, V.T.; Karpukhin, I.V. 1981: Physical therapy of chronic prostatitis Vestnik Khirurgii Imeni I. I. Grekova 127(9): 67-69
Kertes, P.; Goncalves, F.; Stefancik, J.; Dubravicky, J.; Hladik, M.; Breza, J. 2008: Value of antibiotic therapy for bioptically proved chronic prostatitis Bratislavske Lekarske Listy 109(1): 42